Common Equity: The sum of all common equity items.
Pharma Mar (PHMMF) had Common Equity of $208.04M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$40.94M |
|
$-4.16M |
|
$3.58M |
|
$37.35M |
|
$44.19M |
|
$-3.25M |
|
$-0.86M |
|
$-4.11M |
|
$-4.11M |
|
$-4.16M |
|
$-4.16M |
|
$-4.16M |
|
$-4.16M |
|
$-3.25M |
|
$-1.16M |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$248.64M |
|
$57.84M |
|
$102.70M |
|
$351.34M |
|
$83.74M |
|
$40.66M |
|
$59.56M |
|
$143.30M |
|
|
Common Equity |
$208.04M |
$206.97M |
|
$208.04M |
|
-- |
|
| Cash Flow Statement Financials | |
$-6.62M |
|
$11.92M |
|
$-7.18M |
|
$66.62M |
|
$63.52M |
|
$-3.10M |
|
$0.07M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.97 |
|
-- |
|
-- |
|
0.16 |
|
0.25 |
|
91.25% |
|
-7.94% |
|
-7.94% |
|
-- |
|
-10.05% |
|
-10.16% |
|
$-7.15M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
0.07 |
|
1.06 |
|
85.17 |
|
-2.00% |
|
-2.01% |
|
-1.18% |
|
-1.67% |
|
-- |
|
-- |
|
-- |
|